Icosagen

Icosagen Contract Manufacturing & Development (CDMO) Profile

Icosagen Cell Factory is a European Contract Research Development and Manufacturing Organization (CRDMO), focused on recombinant protein production from mammalian cells. With our combined CRO and CDMO capabilities, we discover, develop and manufacture protein drug candidates, seamlessly from research concepts into pre-clinical and clinical development stages, i. e. from discovery to transient R&D milligrams, stable cell line development and clinical GMP kilograms.

CDMO Services:
Biologics Drug Substance Manufacturing (API); Research & Development; Clinical Trials materials and logistics; Analytical Development Liquids

Year Founded: 1999

Head Office: Õssu, Estonia

Number of Facilities: 1

Facility locations: Europe

Website: Visit the Icosagen website

Linkedin: Connect on Linkedin

Current Capacity: Prec-linivcal, non GMP grade:

From 96-well plates to 24-well, 6-well, from 50ml to intemediate volumes up to 5L shake flasks, ambr15ml and ambr 250ml bioreactor systems, 3L single use moebius bioreactors, 10L glass BR’s (Sartorius),

Clinical, GMP-grade:

50L, 200L and 1000L single use Moebius bioreactors